Slaughter and May is advising Aston Martin Lagonda Global Holdings plc (“Aston Martin Lagonda” or the “Company”), the iconic producer of hand-crafted luxury sports cars, on the proposed initial public offering of ordinary shares (the “Offer”).  The Offer price was set at £19 per share, resulting in a total market capitalisation of the Company of approximately £4.33 billion at the commencement of conditional dealings on the Main Market of the London Stock Exchange on 3 October 2018.   Admission of the shares to the premium listin

International law firm Ashurst advised Commonwealth Securities Limited, National Australia Bank Limited and Crestone Wealth Management Limited, as joint lead arrangers, of the proposed initial public offering by Heart and Minds Investments Limited to raise up to A$500 million and listing on ASX.

Davis Polk advised Arco Platform Limited in connection with its SEC-registered initial public offering of an aggregate of 12,777,777 Class A common shares, at a price per Class A common share of $17.50 (including the full exercise of the underwriters' overallotment option). The initial public offering raised gross proceeds of $223.6 million. The Class A common shares are listed on the NASDAQ Global Select Market under the symbol "ARCE."

Kirkland & Ellis advises Bain Capital Private Equity (Europe) LLP and Cinven Partners LLP on a public delisting tender offer for all remaining shares of STADA Arzneimittel AG. The offer price equals to the six months weighted average stock exchange price estimated to be EUR 81.83 per STADA share. The total value of the offer amounts to approx. EUR 1.8 billion. Two shareholders under joint control have already undertaken to accept the offer with all shares held by them (approx. 12% of the outstanding STADA shares).

Hogan Lovells has advised Valneva in its €50 million fundraising of gross proceeds in a private placement of its ordinary shares.

The transaction led by blue-chip US healthcare investors and supported by the Company’s existing major shareholders, was heavily oversubscribed.

Valneva is a commercial stage biotech company focused on developing innovative lifesaving vaccines. This investment supports its capital access strategy and future growth, including the acceleration of its key development programs.

Sidley represented A-shares listed company Shandong Gold Mining Co., Ltd. (HKEX: 1787) (Shandong Gold), as the issuer’s Hong Kong and U.S. Counsel in its HK$4.64 billion (approximately US$594 million) global offering and listing of H-Shares on the Main Board of the Hong Kong Stock Exchange.

Shandong Gold is engaged in the mining and smelting of gold.

Simpson Thacher represented Qutoutiao Inc. (“Qutoutiao”) in connection with its initial public offering and listing on the NASDAQ Global Select Market. The offering was comprised of 13,800,000 American Depositary Shares, representing 3,450,000 Class A ordinary shares, including full exercise of the underwriters’ overallotment option. The total offering size was US$96.6 million. Citigroup and Deutsche Bank Securities as well as China Merchants Securities (HK) and UBS Investment Bank acted as representatives to the underwriters of the offering.

Sidley advised Haidilao International Holding Ltd. (HKEX: 6862) (Haidilao) in connection with its HK$7.56 billion (approximately US$964 million) initial public offering listed on the Stock Exchange of the Hong Kong Main Board.

Haidilao International Holding Ltd. is a globally leading and fast-growing Chinese cuisine restaurant brand focusing on hot pot cuisine.